Progress in psoriasis therapy via novel drug delivery systems

Psoriasis is a lifelong condition which is caused by the negative signals produced by immune system, which leads to hyper proliferation and other inflammatory reactions on the skin. In this case, keratinocytes which are the outermost layer of skin possess shortened life cycle and results in the alte...

Full description

Bibliographic Details
Main Authors: Nitha Vincent, Ramya Devi D, Vedha Hari BN
Format: Article
Language:English
Published: PAGEPress Publications 2014-09-01
Series:Dermatology Reports
Subjects:
Online Access:http://www.pagepress.org/journals/index.php/dr/article/view/5451
_version_ 1818470252202164224
author Nitha Vincent
Ramya Devi D
Vedha Hari BN
author_facet Nitha Vincent
Ramya Devi D
Vedha Hari BN
author_sort Nitha Vincent
collection DOAJ
description Psoriasis is a lifelong condition which is caused by the negative signals produced by immune system, which leads to hyper proliferation and other inflammatory reactions on the skin. In this case, keratinocytes which are the outermost layer of skin possess shortened life cycle and results in the alteration of desquamation process where the cytokines will come out through lesions of affected patients and as a result, scaling marks appears on the skin. These conditions may negatively affect the patient’s quality of life and lead to psychosocial stress. Psoriasis can be categorized as mild, moderate and severe conditions. Mild psoriasis leads to the formation of rashes, and when it becomes moderate, the skin turns into scaly. In severe conditions, red patches may be present on skin surface and becomes itchy. Topical therapy continues to be one of the pillars for psoriasis management. Drug molecules with target effect on the skin tissues and other inflammations should be selected for the treatment of psoriasis. Most of the existing drugs lead to systemic intoxication and dryness when applied in higher dose. Different scientific approaches for topical delivery are being explored by researches including emollient, modified gelling system, transdermal delivery, spray, nanogels, hydrogels, micro/nano emulsion, liposomes, nano capsules etc. These topical dosage forms are evaluated for various physico chemical properties such as drug content, viscosity, pH, extrudability, spreadability, toxicity, irritancy, permeability and drug release mechanism. This review paper focus attention to the impact of these formulation approaches on various anti-psoriasis drugs for their successful treatment.
first_indexed 2024-04-13T21:35:01Z
format Article
id doaj.art-1bcb787d5baf4cb59e9fae0852d0fb61
institution Directory Open Access Journal
issn 2036-7392
2036-7406
language English
last_indexed 2024-04-13T21:35:01Z
publishDate 2014-09-01
publisher PAGEPress Publications
record_format Article
series Dermatology Reports
spelling doaj.art-1bcb787d5baf4cb59e9fae0852d0fb612022-12-22T02:29:01ZengPAGEPress PublicationsDermatology Reports2036-73922036-74062014-09-016110.4081/dr.2014.54512906Progress in psoriasis therapy via novel drug delivery systemsNitha Vincent0Ramya Devi D1Vedha Hari BN2Department of Pharmaceutical Technology, School of Chemical and Biotechnology, SASTRA University, ThanjavurDepartment of Pharmaceutical Technology, School of Chemical and Biotechnology, SASTRA University, ThanjavurDepartment of Pharmaceutical Technology, School of Chemical and Biotechnology, SASTRA University, ThanjavurPsoriasis is a lifelong condition which is caused by the negative signals produced by immune system, which leads to hyper proliferation and other inflammatory reactions on the skin. In this case, keratinocytes which are the outermost layer of skin possess shortened life cycle and results in the alteration of desquamation process where the cytokines will come out through lesions of affected patients and as a result, scaling marks appears on the skin. These conditions may negatively affect the patient’s quality of life and lead to psychosocial stress. Psoriasis can be categorized as mild, moderate and severe conditions. Mild psoriasis leads to the formation of rashes, and when it becomes moderate, the skin turns into scaly. In severe conditions, red patches may be present on skin surface and becomes itchy. Topical therapy continues to be one of the pillars for psoriasis management. Drug molecules with target effect on the skin tissues and other inflammations should be selected for the treatment of psoriasis. Most of the existing drugs lead to systemic intoxication and dryness when applied in higher dose. Different scientific approaches for topical delivery are being explored by researches including emollient, modified gelling system, transdermal delivery, spray, nanogels, hydrogels, micro/nano emulsion, liposomes, nano capsules etc. These topical dosage forms are evaluated for various physico chemical properties such as drug content, viscosity, pH, extrudability, spreadability, toxicity, irritancy, permeability and drug release mechanism. This review paper focus attention to the impact of these formulation approaches on various anti-psoriasis drugs for their successful treatment.http://www.pagepress.org/journals/index.php/dr/article/view/5451psoriasis, transdermal, emollient, nanogels, microemulsion, liposomes
spellingShingle Nitha Vincent
Ramya Devi D
Vedha Hari BN
Progress in psoriasis therapy via novel drug delivery systems
Dermatology Reports
psoriasis, transdermal, emollient, nanogels, microemulsion, liposomes
title Progress in psoriasis therapy via novel drug delivery systems
title_full Progress in psoriasis therapy via novel drug delivery systems
title_fullStr Progress in psoriasis therapy via novel drug delivery systems
title_full_unstemmed Progress in psoriasis therapy via novel drug delivery systems
title_short Progress in psoriasis therapy via novel drug delivery systems
title_sort progress in psoriasis therapy via novel drug delivery systems
topic psoriasis, transdermal, emollient, nanogels, microemulsion, liposomes
url http://www.pagepress.org/journals/index.php/dr/article/view/5451
work_keys_str_mv AT nithavincent progressinpsoriasistherapyvianoveldrugdeliverysystems
AT ramyadevid progressinpsoriasistherapyvianoveldrugdeliverysystems
AT vedhaharibn progressinpsoriasistherapyvianoveldrugdeliverysystems